StonvexLoading…
StonvexStonvexStonvexCore line items from TALO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $472.31M | $1.78B | $1.39B | $937.78M |
Operating Income | $-119.43M | $-560.28M | $-316.32M | $-230.14M |
Net Income | $-256.17M | $-494.29M | $-291.71M | $-195.81M |
EPS (Diluted) | $-1.52 | $-2.82 | $-1.65 | $-1.10 |
Total Assets | $5.27B | $5.55B | $5.70B | $5.92B |
Total Liabilities | $3.40B | $3.38B | $3.32B | $3.41B |
Cash & Equivalents | $386.37M | $362.81M | $332.69M | $357.29M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 168.38M | 175.14M | 176.94M | 178.79M |